IconOVir Bio, Inc. — Form D

IconOVir Bio, Inc. of New York, NY, a company, filed a Form D exempt-offering notice with the SEC on 2020-12-14. The offering totals $77.0M, of which $77.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (24)

NameRoleLocation
Jakob A LovenDirectorNew York, NY
Sean M AlgeoExecutive OfficerNew York, NY
Sean M AlgeoPromoterNew York, NY
Helen S KimDirectorMenlo Park, CA
Sean A AlgeoExecutive OfficerNew York, NY
Sean A AlgeoPromoterNew York, NY
Nicole M van de LeuvExecutive OfficerNew York, NY
Heba M NowyhedExecutive OfficerNew York, NY
David A ChangDirectorNew York, NY
David A ChangPromoterNew York, NY
William S KaelinDirectorNew York, NY
Jakob S LovenDirectorNew York, NY
Julie A MaltzmanExecutive OfficerNew York, NY
Mark A McCamishDirectorNew York, NY
Mark A McCamishExecutive OfficerNew York, NY
John A HuynhExecutive OfficerNew York, NY
David M TanenExecutive OfficerNew York, NY
David M TanenPromoterNew York, NY
Arie S BelldegrunDirectorNew York, NY
Arie S BelldegrunPromoterNew York, NY
David S ChangDirectorHouston, TX
David S ChangPromoterHouston, TX
Joshua A KazamDirectorSan Mateo, CA
Joshua A KazamPromoterSan Mateo, CA

Other filings by this issuer (2)

FiledFormOfferingSold
2024-06-04D/A$20.2M$20.2M
2023-06-21D$20.2M$20.2M

More